Effect of data normalization for age on the correlations between corneometric values and serum molecule levels in plaque-type psoriatic patients

Acta Dermato-Venereologica

Volumn 77, Issue 2, 1997, Pages 110-114

  Carducci, M ^a   Mussi, A ^a   Bonifati, C ^a   Pietravalle, M ^a   Alemanno, L ^a   Fazio, M ^a   Ameglio, F ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

IL 1Ra; soluble membrane molecule; TGF 1

Indexed keywords

CALCIPOTRIOL; CYCLOSPORIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 2 RECEPTOR; SELECTIN; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA INJURY; CORRELATION FUNCTION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PSORIASIS;

ADULT; AGE FACTORS; AGED; ANALYSIS OF VARIANCE; CELL ADHESION MOLECULES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, INTERLEUKIN-1; SEVERITY OF ILLNESS INDEX; SIALOGLYCOPROTEINS; SKIN; SKIN TESTS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030996175     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carducci M, Mussi A, Bonifati C, Tomaselli R, Onorati MT, Trento E, et al. Correlations of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapy. J Dermatol 1995; 22: 475-479.
2. Bonifati C, Trento E, Carducci M, Sacerdoti G, Mussi A, Fazio M, et al. Soluble E-selectin and soluble tumour necrosis factor receptor (60Kd) serum levels in patients with psoriasis. Dermatology 1995; 190: 128-131.
3. Ameglio F, Bonifati C, Carducci M, Trento E, Mussi A. Tomaselli R, et al. Serum soluble E-selectin levels decrease early during effective therapy in psoriatic patients. Eur J Dermatol 1995; 5: 512-515.
4. Saijo S, Hashimoto-Kumasaka K, Takahashi M, Tagami H. Functional changes of the stratum corneum associated with aging and photoaging. J Soc Cosmet Chem 1991; 42: 379-383.
5. Fredrikson T, Patterson U. Severe psoriasis oral therapy with a new retinoid. Dermatologica 1978; 157: 238-244.
6. Hashimoto-Kumasaka K, Takahashi K, Tagami H. Electrical measurement of the water content of the stratum corneum in vivo and in vitro under various conditions: comparison between skin surface hygrometer and corneometer in evaluation of the skin surface hydration state. Acta Derm Venereol (Stockh) 1993; 73: 335-339.
7. Schopf RE, Nauman S, Rehder M, Morrsches B. Soluble intercellular adhesion molecule-1 levels in patients with psoriasis. Br J Dermatol 1993; 128: 34-37.
8. Kowalzick L, Bildau H, Neubar K, Koehler I, Ring J. Clinical improvement in psoriasis during dithranol/UVB therapy does not correspond with a decrease in elevated serum soluble ICAM-1 levels. Arch Dermatol Res 1993; 285: 233-235.
9. De Rie MA, Hintzen RQ, Witkamp L, Bos JD, van Lier RAW. Quantification of soluble interleukin-2 receptor (CD25) and soluble CD27 in serum from psoriasis patients during cyclosporin A treatment. Acta Derm Venereol (Stockh) 1994: Suppl 186: 128.
10. Mussi A, Carducci M, Bonifati C, Pittarello A, Fazio M, Ameglio F. Are soluble membrane molecules reliable early markers for monitoring psoriasis? G Ital Dermatol Venereol 1995; 130: 73-75.
11. Serup J, Blichmann C. Epidermal hydration of psoriasis plaques and the relation to the scaling. Acta Derm Venereol (Stockh) 1987; 67: 357-366.
12. Regaz A, Ackerman A B. Evolution, maturation and regression of lesions of psoriasis. Am J Dermatopathol 1973; 108: 687-688.
13. Breslaw NE, Day NE. Classical methodology of analysis of grouped data. In 'Statistical methods in cancer research'. Chapter IV. York Scientific publications, n.32. International Agency for research on cancer editions, Lion, 1980: 122-159.
14. Berardesca E, Fideli D, Rabbiosi G. Maibach H. In vivo hydration and water retention capacity of stratum corneum in clinically uninvolved skin in atopic and psoriatic patients. Acta Derm Venereol (Stockh) 1990; 70: 400-404.
15. Ameglio F, Bonifati C, Pietravalle M, Fazio M. Interleukin-6 and tumor necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy. Dermatology 1994; 189: 359-363.
16. Bonifati C, Carducci M, Cordiali Fei P, Trento E, Sacerdoti G, Fazio M, et al. Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity. Clin Exp Dermatol 1994; 19: 383-387.
17. Van de Kerkhof PCM. On the limitation of the psoriasis area and severity index (PASI). Br J Dermatol 1992; 126: 205.
18. Bonifati C, Carducci M, Mussi A, Pittarello A, D'Agosto G, Fazio M, et al. The levels of transforming growth factor-β1 are increased in the serum of patients with psoriasis and correlated with disease severity. Eur J Dermatol 1996; in press.
19. Carducci M, Mussi A, Bonifati C, Fazio M, Ameglio F. sICAM-1, sIL-2R and beta2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severity. Arch Dermatol Res 1994; 286: 420-421.
20. Fazio M, Bonifati C, Alemanno L, Carducci M, Mussi A, Sacerdoti G, et al. Differential behaviour of three soluble membrane molecules in sera and suction blister fluids from lesional and non-lesional skin of psoriatic patients: comparison with skin of normal donors. Eur J Dermatol 1994; 4: 476-479.
21. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993; 23: 2375-2378.